Intestinal Neurofibromatosis Is a Subtype of Familial GIST and Results From a Dominant Activating Mutation in PDGFRA

Gastroenterology

Volumn 131, Issue 6, 2006, Pages 1907-1912

  de Raedt, Thomas ^a   Cools, Jan ^a,b   Debiec Rychter, Maria ^a   Brems, Hilde ^a   Mentens, Nicole ^b   Sciot, Raf ^c   Himpens, Jacques ^d   de Wever, Ivo ^c   Schöffski, Patrick ^c   Marynen, Peter ^a,b   Legius, Eric ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d St Blasius Ziekenhuis   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN S 100;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIT GENE; MOUSE; NEUROFIBROMATOSIS; NF1 GENE; NONHUMAN; PDGFRA GENE; PRIORITY JOURNAL; SOMATIC MUTATION; WESTERN BLOTTING;

EID: 33845644201     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.07.002     Document Type: Article

References (18)

1. Heimann R., Verhest A., Verschraegen J., Grosjean W., Draps J.P., and Hecht F. Hereditary intestinal neurofibromatosis. I. A distinctive genetic disease. Neurofibromatosis 1 (1988) 26-32
2. Lipton S., and Zuckerbrod M. Familial enteric neurofibromatosis. Med Times 94 (1966) 544-548
3. Andersson J., Sihto H., Meis-Kindblom J.M., Joensuu H., Nupponen N., and Kindblom L.G. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 29 (2005) 1170-1176
4. Fletcher C.D., Berman J.J., Corless C., Gorstein F., Lasota J., Longley B.J., Miettinen M., O'Leary T.J., Remotti H., Rubin B.P., Shmookler B., Sobin L.H., and Weiss S.W. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33 (2002) 459-465
5. Corless C.L., Fletcher J.A., and Heinrich M.C. Biology of gastrointestinal stromal tumors. J Clin Oncol 22 (2004) 3813-3825
6. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M., Muhammad Tunio G., Matsuzawa Y., Kanakura Y., Shinomura Y., and Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279 (1998) 577-580
7. Maertens O., Prenen H., Debiec-Rychter M., Wozniak A., Sciot R., Pauwels P., De Wever I., Vermeesch J.R., de Raedt T., De Paepe A., Speleman F., van Oosterom A., Messiaen L., and Legius E. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 15 (2006) 1015-1023
8. Heinrich M.C., Corless C.L., Duensing A., McGreevey L., Chen C.J., Joseph N., Singer S., Griffith D.J., Haley A., Town A., Demetri G.D., Fletcher C.D., and Fletcher J.A. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299 (2003) 708-710
9. Hirota S., Ohashi A., Nishida T., Isozaki K., Kinoshita K., Shinomura Y., and Kitamura Y. Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors. Gastroenterology 125 (2003) 660-667
10. Legius E., Wu R., Eyssen M., Marynen P., Fryns J.P., and Cassiman J.J. Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene. J Med Genet 32 (1995) 316-319
11. Leppig K.A., Viskochil D., Neil S., Rubenstein A., Johnson V.P., Zhu X.L., Brothman A.R., and Stephens K. The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization. Cytogenet Cell Genet 72 (1996) 95-98
12. Menten B., Maas N., Thienpont B., Buysse K., Vandesompele J., Melotte C., de Ravel T., Van Vooren S., Balikova I., Backx L., Janssens S., De Paepe A., De Moor B., Moreau Y., Marynen P., Fryns J.P., Mortier G., Devriendt K., Speleman F., and Vermeesch J.R. Emerging patterns of cryptic chromosomal imbalances in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of the literature. J Med Genet (2006) e-pub
13. Jong K., Marchiori E., Meijer G., Vaart A.V., and Ylstra B. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 20 (2004) 3636-3637
14. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C., Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M., Vandenberghe P., Verhoef G., Boogaerts M., Wlodarska I., Kantarjian H., Marynen P., Coutre S.E., Stone R., and Gilliland D.G. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 (2003) 1201-1214
15. West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S., Montgomery K., Zhu S., Ball C.A., Nielsen T.O., Patel R., Goldblum J.R., Brown P.O., Heinrich M.C., and van de Rijn M. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165 (2004) 107-113
16. Verhest A., Heinmann R., Verschraegen J., Vamos E., and Hecht F. Heredity intestinal neurofibromatosis. II. Translocation between chromosomes 12 and 14. Neurofibromatosis 1 (1988) 33-36
17. Chompret A., Kannengiesser C., Barrois M., Terrier P., Dahan P., Tursz T., Lenoir G.M., and Bressac-De Paillerets B. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology 126 (2004) 318-321
18. Debiec-Rychter M., Wasag B., Stul M., De Wever I., Van Oosterom A., Hagemeijer A., and Sciot R. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. J Pathol 202 (2004) 430-438